American Tungsten & Antimony Limited has successfully produced antimony ingot at its Del Sol Hydromet Refinery in Nevada using ore from its White Spar Antimony Mine in Arizona. This marks the first physical demonstration of the company's US mine-to-metal pathway, supporting its strategy for vertical integration without needing new infrastructure or permits. The milestone highlights the company's vision to create a Critical Mineral Valley in the US, integrating mining, processing, and downstream capabilities. American Tungsten is also developing other critical mineral projects in Utah and Nevada to strengthen its position as a conflict-free supplier to Western economies.
American Tungsten and Antimony's milestone in producing antimony ingot offers context for readers following basic materials. For readers following basic materials, here is Pluang's market snapshot as of Sep 22, 2026 20:11 WIB: of 38 priced Basic Materials-sector US stocks tradable on Pluang, 22 rose and 15 fell today. Notable movers include SBSW at USD 11.32 with a 1-day change of +1.71% and Pluang order activity of 99% Buy, TECK at USD 67.81 with a 1-day change of +1.57% and 100% Buy order activity, and MP at USD 50.71 with a 1-day change of +1.42% and 74% Buy order activity.
MillerKnoll reported a strong Q1 2027 earnings per share (EPS) of $0.53, surpassing analyst expectations by over 51%, helped by tariff refunds and improved cost management. However, its revenue fell 3.4% year-over-year to $923.40 million, missing est...
THOR Industries reported Q4 earnings with an EPS of $0.78, missing analyst estimates and showing a 66.9% drop from last year. Despite this, the company beat revenue expectations with $2.31 billion, though revenue declined 8.4% year-over-year due to w...
Cracker Barrel Old Country Store is set to report its Q3 2026 earnings on September 23, with analysts predicting a significant decline. Earnings per share are expected to fall to $0.17 from $0.74 last year, and revenue is forecasted around $834.57 mi...
Abivax received positive pre-NDA feedback from the U.S. FDA for its drug Obefazimod, marking a key step in its development. Despite a recent price target cut by Wedbush to $118, analysts maintain a "Moderate Buy" consensus with an average target of $...
HSBC and Wells Fargo have downgraded Netflix stock due to declining subscriber engagement and an 8% drop in viewership time. Despite a recent 2.19% stock gain, Netflix shares have fallen over 40% in the past year amid strong competition and weaker or...
